StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) KPIs and segments

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.30−2.69 (-6.26%)

Close on Nov 17, 2026Market cap $1.30BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive LB Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to LB Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?